MedPath

Suture of the Ovary After Enucleation of Ovarian Endometrioma

Not Applicable
Not yet recruiting
Conditions
Endometrioma
Interventions
Procedure: No suture of the ovarian cortex
Procedure: Suture of the ovarian cortex
Registration Number
NCT03788720
Lead Sponsor
Università degli Studi dell'Insubria
Brief Summary

Endometriosis is an estrogen-dependent chronic disease, characterized by the presence of ectopic endometrial-like tissue outside the uterine cavity.

According to the most updated guidelines of the European Society of Human Reproduction and Embryology (ESHRE), infertile women with endometriomas smaller than 3 cm should be addressed directly to Assisted Reproduction Technology (ART); conversely, for infertile women with endometriomas larger than 3 cm, enucleation of ovarian endometriomas could be considered in order to improve reproductive outcomes (both spontaneous and ART pregnancy rate).

To date, literature data do not allow to draw a firm conclusion about the best strategy to reduce ovarian damage during enucleation of ovarian endometriomas: in particular, investigators still lack robust evidence in order to choose between suturing the ovary or not after the enucleation.

In this scenario, the aim of our the study will be to compare functional outcomes of the ovary in a group of women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas (cases) and a group of women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Women affected by one primary (no recurrent) monolateral ovarian endometrioma, with maximum diameter between 5 and 10 cm, undergoing laparoscopic enucleation by stripping technique;
  • Normal AFC at the enrollment (baseline).
Exclusion Criteria
  • Any other disease;
  • Bilateral endometriomas;
  • Deep infiltrating endometriosis;
  • No previous pelvic surgery (even not gynecological);
  • Any other pharmacologic and non pharmacologic treatment in the previous 3 months (wash-out period);

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
No sutureNo suture of the ovarian cortexWomen undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.
SutureSuture of the ovarian cortexWomen undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas.
Primary Outcome Measures
NameTimeMethod
Antral Follicle Count (AFC)Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery

AFC will be evaluated on day 3 of the cycle by a transvaginal ultrasound. Initially the ovarian volume of both the ovaries is calculated. Further the number of small antral follicles in both the ovaries is measured. These follicles could vary in size from 2-10 mm.

Secondary Outcome Measures
NameTimeMethod
Ovarian volumeChange from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery

Evaluation of the ovarian volume calculated using the prolate ellipsoid formula (length x height x width x 0.523)

Pulsatility index, evaluated by Doppler flowmetry, of the ovarian arteryChange from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery

Evaluation of the pulsatility index (PI; minimum: 0; maximum: 7; higher values represent a better outcome) of the ovarian artery.

Resistive index, evaluated by Doppler flowmetry, of the ovarian arteryChange from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery

Evaluation of the resistive index (RI minimum: 0; maximum: 3; higher values represent a worse outcome) of the ovarian artery.

Trial Locations

Locations (1)

"Filippo Del Ponte" Hospital

🇮🇹

Varese, Italy

© Copyright 2025. All Rights Reserved by MedPath